Literature DB >> 35063305

Veterans Crisis Line Call Outcomes: Distress, Suicidal Ideation, and Suicidal Urgency.

Peter C Britton1, Elizabeth Karras2, Tracy Stecker3, John Klein4, Dev Crasta2, Lisa A Brenner5, Wilfred R Pigeon2.   

Abstract

INTRODUCTION: This study evaluates the effectiveness of the Veterans Crisis Line on immediate call outcomes (i.e., caller distress, suicidal ideation, and suicidal urgency) for veterans who provide identifying information.
METHODS: Coders rated pre- and post-distress, suicidal ideation, and suicidal urgency for 647 calls from 2019 veteran callers. Intraclass correlation coefficients examined inter-rater reliability. Multilevel generalized linear modeling examined pre-post changes.
RESULTS: Inter-rater reliability was good for distress, excellent for suicidal ideation, and fair for urgency. Callers had 5 times greater odds of a reduction in distress (AOR=5.03, 95% CI=3.98, 6.49), almost 5 times greater odds of a reduction in suicidal ideation (AOR=4.92, 95% CI=3.49, 6.94), and 11 times greater odds of a reduction in suicidal urgency (AOR=11.01, 95% CI=2.72, 44.50) at the end of calls than at the beginning.
CONCLUSIONS: Veterans Crisis Line callers who provide identifying information experience reductions in distress and suicidal ideation during the call. Research is needed to examine the reduction in suicidal urgency because of fair reliability, generalizability of results to other callers, post-call treatment contact and engagement, and risk for suicide attempts and death. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2022        PMID: 35063305     DOI: 10.1016/j.amepre.2021.11.013

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  1 in total

1.  Automated Workflow for Usability Audits in the PHR Realm.

Authors:  José A García-Berná; Raimel Sobrino-Duque; Juan M Carrillo de Gea; Joaquín Nicolás; José L Fernández-Alemán
Journal:  Int J Environ Res Public Health       Date:  2022-07-22       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.